Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCSW) Profit After Tax (2021 - 2025)

Historic Profit After Tax for HeartSciences (HSCSW) over the last 5 years, with Q4 2025 value amounting to -$2.4 million.

  • HeartSciences' Profit After Tax fell 1285.94% to -$2.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$9.0 million, marking a year-over-year decrease of 1851.65%. This contributed to the annual value of -$8.8 million for FY2025, which is 3270.18% down from last year.
  • HeartSciences' Profit After Tax amounted to -$2.4 million in Q4 2025, which was down 1285.94% from -$2.1 million recorded in Q3 2025.
  • HeartSciences' Profit After Tax's 5-year high stood at -$501851.0 during Q3 2021, with a 5-year trough of -$2.5 million in Q1 2025.
  • Over the past 5 years, HeartSciences' median Profit After Tax value was -$1.8 million (recorded in 2022), while the average stood at -$1.7 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first tumbled by 21350.0% in 2022, then surged by 2049.43% in 2023.
  • Quarter analysis of 5 years shows HeartSciences' Profit After Tax stood at -$1.0 million in 2021, then tumbled by 74.58% to -$1.8 million in 2022, then increased by 3.22% to -$1.7 million in 2023, then decreased by 19.13% to -$2.1 million in 2024, then dropped by 12.86% to -$2.4 million in 2025.
  • Its Profit After Tax stands at -$2.4 million for Q4 2025, versus -$2.1 million for Q3 2025 and -$2.1 million for Q2 2025.